EPH125 Potential Health Effects of a Blood-Based Genomic Test Used to Prescreen Individuals Eligible for Lung Cancer Screening in the U.S.
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.1046
https://www.valueinhealthjournal.com/article/S1098-3015(22)03251-X/fulltext
Section Title :
Section Order :
10595
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03251-X&doi=10.1016/j.jval.2022.09.1046